eoadjuvant chemoradiotheraphy in patients with locally advanced gastric cancer

Phase 2

• Conditions: Condition 1: Proximal gastric cancer. Condition 2: Gastro-oesophageal cancer.; Fundus of stomach; Gastro-oesophagea cancerl

• Registration Number: IRCT2014072015044N1
• Lead Sponsor: Vice chancellor for research, Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

The main inclusion criteria: All patients with locally advanced proximal gastric cancer and esophagogastric cancer who have positive biopsy results and has been filled the consent form informally.
The main exclusion criteria: patients (illness) at stage I and IV; patient dissatisfaction; comorbid diseases that prevent oncologic treatment; previous cancer; previous chemotherapy or radiotherapy; hepatic and renal dysfunction that prevents oncologic treatments; Performance status 3,4 ECOG

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evaluation of resectability rate and tumor response in patients with locally advanced proximal gastric cancer and esophagogastric cancer treated with neoadjuvant chemoradiotheraphy. Timepoint: Pathologic Evaluation of surgical specimen. Method of measurement: Pathologic response.

Secondary Outcome Measures

Name	Time	Method
Rate of surgical copmplication. Timepoint: Post operation. Method of measurement: Incisional leek,post op mortality.